Centene Corporation is an American for-profit healthcare company based in St. Louis, Missouri, which is an intermediary for government-sponsored and privately insured healthcare programs. Centene ranked No. 23 on the 2025 Fortune 500.
| trading_symbol | registrant_name | time | price | change | percentage_change |
|---|---|---|---|---|---|
| CNC | CENTENE CORP | 2025-10-17 00:11:21 | 35.55 | -0.09 | -0.25 |
| trading_symbol | central_index_key | registrant_name | isin_number | lei_number | ein_number | exchange | sic_code | sic_description | fiscal_year_end | state_of_incorporation | address_street | address_city | address_state | address_zip_code | address_country | address_country_code | phone_number | mailing_address | business_address | former_name | industry | founding_date | chief_executive_officer | number_of_employees | website | market_cap | shares_issued | shares_outstanding | description | update_time |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CNC | 0001071739 | CENTENE CORP | US15135B1017 | 549300Z7JJ4TQSQGT333 | 041406317 | NYSE | 6324 | Hospital & Medical Service Plans | 1231 | DE | 7700 FORSYTH BLVD. | ST LOUIS | MO | 63105 | UNITED STATES | US | 3147254477 | 7700 FORSYTH BLVD., ST LOUIS, MO, 63105 | 7700 FORSYTH BLVD., ST LOUIS, MO, 63105 | — | Managed healthcare | 1984 | Sarah London | 60,500 | https://www.centene.com/ | 34,900,000,000 | 622,834,000 | 491,133,000 | Centene Corporation is an American for-profit healthcare company based in St. Louis, Missouri, which is an intermediary for government-sponsored and privately insured healthcare programs. Centene ranked No. 23 on the 2025 Fortune 500. | 2025-10-10 19:34:38 |
| Fiscal Year | Market Cap | Change In Market Cap | Percentage Change In Market Cap | Shares Outstanding | Change In Shares Outstanding | Percentage Change In Shares Outstanding |
|---|---|---|---|---|---|---|
| 2024 | 34,900,000,000 | -1,900,000,000 | -5.163 | 496,044,000 | -38,819,000 | -7.2577 |
| 2023 | 36,800,000,000 | -12,400,000,000 | -25.2033 | 534,863,000 | -16,401,559 | -2.9753 |
| 2022 | 49,200,000,000 | 6,700,000,000 | 15.7647 | 551,264,559 | -31,601,311 | -5.4217 |
| Executive Name | Executive Position | Fiscal Year | Salary | Bonus | Stock Awards | Incentive Plan Compensation | Other Compensation | Total Compensation |
|---|---|---|---|---|---|---|---|---|
| Kenneth J. Fasola | President | 2024 | 1,100,000 | 0 | 6,229,423 | 1,598,000 | 95,778 | 9,023,201 |
| Christopher A. Koster | Secretary, General Counsel | 2024 | 750,000 | 0 | 2,920,884 | 1,352,250 | 40,404 | 5,063,538 |
| Sarah M. London | Chief Executive Officer | 2024 | 1,400,000 | 0 | 14,630,132 | 4,289,125 | 282,891 | 20,602,148 |
| Andrew L. Asher | Chief Financial Officer | 2024 | 1,025,000 | 0 | 7,179,353 | 2,779,925 | 198,134 | 11,182,412 |
| Susan R. Smith | Chief Operating Officer | 2024 | 696,154 | 0 | 1,654,307 | 1,099,923 | 72,068 | 3,522,452 |
| Fiscal Year | Employee Count |
|---|---|
| 2022 | 15,000 |
| 2020 | 71,300 |
| 2019 | 56,600 |
| Fiscal Year | 2024 | 2023 | 2022 |
|---|---|---|---|
| Revenue | 163,071,000,000 | 153,999,000,000 | 144,547,000,000 |
| Cost Of Revenue | 2,729,000,000 | 3,564,000,000 | 7,032,000,000 |
| Gross Profit | 17,069,000,000 | 17,637,000,000 | — |
| Research And Development Expenses | — | — | — |
| General And Administrative Expenses | 12,400,000,000 | 12,563,000,000 | 11,589,000,000 |
| Operating Expenses | 159,896,000,000 | 151,069,000,000 | 143,229,000,000 |
| Operating Income | 3,175,000,000 | 2,930,000,000 | 1,318,000,000 |
| Net Income | 3,305,000,000 | 2,702,000,000 | 1,202,000,000 |
| Earnings Per Share Basic | 6.33 | 4.97 | 2.09 |
| Earnings Per Share Diluted | 6.31 | 4.95 | 2.07 |
| Weighted Average Shares Outstanding Basic | 521,790,000 | 543,319,000 | 575,191,000 |
| Weighted Average Shares Outstanding Diluted | 523,744,000 | 545,704,000 | 582,040,000 |
| Fiscal Year | 2024 | 2023 | 2022 |
|---|---|---|---|
| Cash And Cash Equivalents | 14,063,000,000 | 17,193,000,000 | 12,074,000,000 |
| Marketable Securities Current | 2,622,000,000 | 2,459,000,000 | 2,321,000,000 |
| Accounts Receivable | 19,713,000,000 | 15,532,000,000 | 13,272,000,000 |
| Inventories | — | — | — |
| Non Trade Receivables | — | — | — |
| Other Assets Current | 1,601,000,000 | 5,572,000,000 | 2,461,000,000 |
| Total Assets Current | 37,999,000,000 | 40,756,000,000 | 30,128,000,000 |
| Marketable Securities Non Current | 17,429,000,000 | 16,286,000,000 | 14,684,000,000 |
| Property Plant And Equipment | 2,067,000,000 | 2,019,000,000 | 2,432,000,000 |
| Other Assets Non Current | 593,000,000 | 535,000,000 | 2,686,000,000 |
| Total Assets Non Current | 44,446,000,000 | 43,885,000,000 | 46,742,000,000 |
| Total Assets | 82,445,000,000 | 84,641,000,000 | 76,870,000,000 |
| Accounts Payable | 13,174,000,000 | 16,420,000,000 | 9,525,000,000 |
| Deferred Revenue | 661,000,000 | 715,000,000 | 478,000,000 |
| Short Term Debt | 110,000,000 | 119,000,000 | 82,000,000 |
| Other Liabilities Current | 243,000,000 | 417,000,000 | 534,000,000 |
| Total Liabilities Current | 34,261,000,000 | 36,716,000,000 | 28,464,000,000 |
| Long Term Debt | 18,640,000,000 | 17,962,000,000 | 18,179,000,000 |
| Other Liabilities Non Current | 2,567,000,000 | 3,618,000,000 | 5,616,000,000 |
| Total Liabilities Non Current | 21,674,000,000 | 21,969,000,000 | 24,169,000,000 |
| Total Liabilities | 55,935,000,000 | 58,685,000,000 | 52,633,000,000 |
| Common Stock | 1,000,000 | 1,000,000 | 1,000,000 |
| Retained Earnings | 15,348,000,000 | 12,043,000,000 | 9,341,000,000 |
| Accumulated Other Comprehensive Income | -504,000,000 | -652,000,000 | -1,132,000,000 |
| Total Shareholders Equity | 26,410,000,000 | 25,840,000,000 | 24,057,000,000 |
| Fiscal Year | 2024 | 2023 | 2022 |
|---|---|---|---|
| Depreciation And Amortization | 1,241,000,000 | 1,293,000,000 | 1,553,000,000 |
| Share Based Compensation Expense | 212,000,000 | 216,000,000 | 234,000,000 |
| Other Non Cash Income Expense | -16,000,000 | -172,000,000 | 31,000,000 |
| Change In Accounts Receivable | — | — | — |
| Change In Inventories | — | — | — |
| Change In Non Trade Receivables | — | — | — |
| Change In Other Assets | -46,000,000 | -5,000,000 | -128,000,000 |
| Change In Accounts Payable | -528,000,000 | 3,398,000,000 | 421,000,000 |
| Change In Other Liabilities | — | — | — |
| Cash From Operating Activities | 154,000,000 | 8,053,000,000 | 6,261,000,000 |
| Purchases Of Marketable Securities | 7,183,000,000 | 6,622,000,000 | 6,736,000,000 |
| Sales Of Marketable Securities | 5,785,000,000 | 5,523,000,000 | 3,802,000,000 |
| Acquisition Of Property Plant And Equipment | 644,000,000 | 799,000,000 | 1,004,000,000 |
| Acquisition Of Business | 0 | 0 | 1,460,000,000 |
| Other Investing Activities | 0 | 0 | 0 |
| Cash From Investing Activities | -1,052,000,000 | -1,191,000,000 | -2,921,000,000 |
| Tax Withholding For Share Based Compensation | — | — | — |
| Payments Of Dividends | 321,000,000 | 85,000,000 | 10,000,000 |
| Issuance Of Common Stock | 46,000,000 | 44,000,000 | 70,000,000 |
| Repurchase Of Common Stock | 3,124,000,000 | 1,633,000,000 | 3,096,000,000 |
| Issuance Of Long Term Debt | 1,300,000,000 | 2,335,000,000 | 360,000,000 |
| Repayment Of Long Term Debt | 622,000,000 | 2,316,000,000 | 1,490,000,000 |
| Other Financing Activities | -6,000,000 | 0 | -27,000,000 |
| Cash From Financing Activities | -2,406,000,000 | -1,658,000,000 | -4,197,000,000 |
| Change In Cash | -3,296,000,000 | 5,172,000,000 | -868,000,000 |
| Cash At End Of Period | 14,063,000,000 | 17,193,000,000 | 12,074,000,000 |
| Income Taxes Paid | 1,002,000,000 | 883,000,000 | 1,222,000,000 |
| Interest Paid | 688,000,000 | 688,000,000 | 657,000,000 |
| Fiscal Year | 2024 | 2023 | 2022 |
|---|---|---|---|
| Earnings Per Share | 6.33 | 4.97 | 2.09 |
| Price To Earnings Ratio | 9.5703 | 14.9316 | 39.2392 |
| Earnings Growth Rate | 27.3642 | 137.799 | -9.5238 |
| Price Earnings To Growth Ratio | 0.3497 | 0.1084 | -4.1201 |
| Book Value Per Share | 50.8059 | 47.773 | 42.1373 |
| Price To Book Ratio | 1.1924 | 1.5534 | 1.9463 |
| Ebitda | 6,250,000,000 | 5,603,000,000 | 4,642,000,000 |
| Enterprise Value | 36,297,038,200 | 41,207,702,990 | 53,358,413,910 |
| Dividend Yield | 0.0102 | 0.0021 | 0.0002 |
| Dividend Payout Ratio | 0.0971 | 0.0315 | 0.0083 |
| Debt To Equity Ratio | 0.71 | 0.6997 | 0.7591 |
| Capital Expenditures | 1,289,000,000 | 880,000,000 | 594,000,000 |
| Free Cash Flow | -1,135,000,000 | 7,173,000,000 | 5,667,000,000 |
| Return On Equity | 0.1251 | 0.1046 | 0.05 |
| One Year Beta | 0.2697 | 0.4794 | 0.5949 |
| Three Year Beta | 0.5099 | 0.5576 | 0.9024 |
| Five Year Beta | 0.822 | 0.8808 | 0.932 |
| Insider Name | Relationship To Issuer | Transaction Date | Amount Of Securities | Acquired Or Disposed | Securities Owned Following Transaction |
|---|---|---|---|---|---|
| Burdick Kenneth A | Director | 2025-09-30 | 852 | A | 338,371 |
| COUGHLIN CHRISTOPHER J | Director | 2025-09-30 | 852 | A | 12,287 |
| EPPINGER FREDERICK H | Director | 2025-09-30 | 710 | A | 359,752 |
| Samuels Theodore R. II | Director | 2025-09-30 | 710 | A | 19,204 |
| TANJI KENNETH | Director | 2025-09-30 | 803 | A | 5,948 |
| Name Of Reporting Person | Report Date | State | Transaction Type | Transaction Date | Owner Type | Amount |
|---|---|---|---|---|---|---|
| Valerie Hoyle | 2025-09-12 | OR04 | Purchase | 2024-10-29 | Spouse | $1,001 - $15,000 |
| Gilbert Cisneros | 2025-09-12 | CA31 | Purchase | 2025-08-05 | — | $1,001 - $15,000 |
| Tim Moore | 2025-09-03 | NC14 | Purchase | 2025-08-07 | — | $15,001 - $50,000 |
| Tim Moore | 2025-09-03 | NC14 | Purchase | 2025-08-08 | — | $1,001 - $15,000 |
| Tim Moore | 2025-09-03 | NC14 | Sale | 2025-08-18 | — | $100,001 - $250,000 |
| Investor Name | Period Of Report | Market Value | Amount Of Securities | Price Per Security |
|---|---|---|---|---|
| Capital Advisors, Ltd. LLC | 2025-09-30 | 7,000 | 202 | 34.6535 |
| Gleason Group, Inc. | 2025-09-30 | 35,680 | 1,000 | 35.68 |
| BURNEY CO/ | 2025-09-30 | 311,212 | 8,722 | 35.6813 |
| PFS Partners, LLC | 2025-09-30 | 1,677 | 47 | 35.6809 |
| NVWM, LLC | 2025-09-30 | 1,249 | 35 | 35.6857 |
| Registrant Name | Period Of Report | Fund Name | Fund Symbol | Amount Of Units | Value In Usd | Percentage Value Compared To Assets |
|---|---|---|---|---|---|---|
| TRUST FOR PROFESSIONAL MANAGERS | 2025-08-31 | Column Mid Cap Fund | CFMCX | 76,808 | 2,230,504.32 | 0.2238 |
| TRUST FOR PROFESSIONAL MANAGERS | 2025-08-31 | Column Mid Cap Select Fund | CFMSX | 342,592 | 9,948,871.68 | 0.3833 |
| ETF Series Solutions | 2025-07-31 | Aptus Large Cap Enhanced Yield ETF | DUBS | 2,868 | 74,768.76 | 0.0313 |
| ETF Series Solutions | 2025-07-31 | Aptus Large Cap Upside ETF | UPSD | 10,234 | 266,800.38 | 0.3234 |
| Pacer Funds Trust | 2025-07-31 | Pacer Trendpilot US Large Cap ETF | PTLC | 30,704 | 800,453.28 | 0.024 |